MEDICINOVA, INC. Foreign Currency Transaction Gain (Loss), before Tax
MEDICINOVA, INC. (MNOV) reported Foreign Currency Transaction Gain (Loss), before Tax of $9.23 thousand for the 3-month period ending 2011-09-30, per its 10-Q filed 2011-11-14.
Discontinued › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2011-11-14
- MEDICINOVA, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2011-09-30 was $9.23K, a 205.19% increase year-over-year.
- MEDICINOVA, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2011-06-30 was -$186.00, a 109.21% decline year-over-year.
- MEDICINOVA, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2010-09-30 was $3.02K.
- MEDICINOVA, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2010-06-30 was $2.02K.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 129 month | Foreign Currency Transaction Gain (Loss), before Tax 132 month |
|---|---|---|---|---|---|
| 2011-09-30 | $9.23K 10-Q · filed 2011-11-14 | $9.04K derived: sum of 2 quarters · filed 2011-11-14 | $9.40K 10-Q · filed 2011-11-14 | -$88.42K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | -$186.00 10-Q · filed 2011-08-15 | $172.00 10-Q · filed 2011-08-15 | -$97.65K 10-Q · filed 2011-08-15 | ||
| 2010-09-30 | $3.02K 10-Q · filed 2011-11-14 | $5.04K derived: sum of 2 quarters · filed 2011-11-14 | $1.29K 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $2.02K 10-Q · filed 2011-08-15 | -$1.73K 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |